Lorazepam: Difference between revisions

(Add dynamic SMW Indications by Condition table (auto-populated from disease pages via MedicationDose template))
(Switch SMW query from broadtable to table format for better layout with TOC)
 
(One intermediate revision by the same user not shown)
Line 75: Line 75:
  |?Has Route=Route
  |?Has Route=Route
  |?Has Population=Population
  |?Has Population=Population
  |format=broadtable
  |format=table
  |headers=plain
  |headers=plain
  |link=subject
  |mainlabel=-
  |sort=Has Indication
  |sort=Has Indication
  |limit=50
  |limit=50

Latest revision as of 21:56, 20 March 2026

General

  • Type: Benzodiazepine
  • Dosage Forms: Tablet: 0.5, 1, 2 mg. IV solution: 2mg/ml, 4 mg/ml
  • Common Trade Names: Ativan

Adult Dosing

Pediatric Dosing

Seizure

  • 0.1 mg/kg IV

Special Populations[1]

  • Pregnancy Rating:
  • Lactation:
    • Lorazepam is present in breast milk
  • Renal Dosing
    • Adult
      • PO: no adjustment necessary
      • IV:
        • Mild to moderate impairment
          • No adjustment necessary
        • Severe impairment
          • Use not recommended
    • Pediatric
      • PO: not defined
      • IV:
        • Mild to moderate impairment
          • No adjustment necessary
        • Severe impairment
          • Use not recommended
  • Hepatic Dosing
    • Adult
      • PO:
        • Mild to moderate impairment: No adjustment necessary
        • Severe impairment: May need lower doses, use caution
      • IV:
        • Mild to moderate impairment: No adjustment necessary
        • Severe impairment: Use not recommended
    • Pediatric
      • ≥ 12 years old: No adjustment necessary however use caution with severe hepatic disease

Contraindications

  • Allergy to class/drug
  • Respiratory depression

Adverse Reactions

Serious

  • Respiratory depression
  • apnea
  • hypotension
  • paradoxical CNS stimulation

Common

  • sedation
  • ataxia
  • disinhibition
  • dysarthria

Pharmacology

  • Half-life: 10-20 hours
  • Metabolism: liver
  • Excretion: renal
  • Mechanism of Action: GABA receptor agonist


Indications by Condition

The following table is automatically generated from disease/condition pages across WikEM.

IndicationDoseContextRoutePopulation
Agitated or combative patient2 mg IV/IMBenzodiazepine for agitationIV/IMAdult
Cannabinoid hyperemesis syndrome1-2mg IVAnxiolytic/antiemeticIVAdult
Cholinergic crisis2-4mg IVSeizure controlIVAdult
Ethanol withdrawal1-4 mg IV q15-20min (titrated to effect)1st line benzodiazepine (medium-acting, preferred in liver disease)IVAdult

See Also

References

  1. Lorazepam: Drug information. UpToDate. www.uptodate.com. Accessed April 2, 2019.